An investigation into a protein that helps to lubricate human joints could help to open up new avenues for treating a rare genetic musculoskeletal condition that has no current treatment. A poster presented at MLS Future Forum illuminated the important role of lubricin in patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis (CACP).
